Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Langkjaer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Pharmaceutica Nordica|January 1, 1992
Chemical stability of insulin. 3. Influence of excipients, formulation, and pHJ Brange, L Langkjaer
Pharmaceutical Biotechnology|January 1, 1997
Insulin formulation and deliveryJ Brange, L Langkjaer
Pharmaceutical Research|June 1, 1992
Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparationsJ Brange, L Langkjaer, S Havelund, et al.
BMJ (Clinical Research Ed.)|August 12, 1989
NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogueS Jørgensen, A Vaag, L Langkjaer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 1998
Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatmentL Langkjaer, J Brange, G M Grodsky, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1992
Insulin analogues with improved absorption characteristicsJ Brange, J F Hansen, L Langkjaer, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 1, 1992
Application of the euglycaemic clamp technique to bioassay of insulin analoguesA Vłlund, U Ribel, P L Dam, et al.
Protein Engineering|June 1, 1987
Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30J Markussen, I Diers, A Engesgaard, et al.
Protein Engineering|July 1, 1988
Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30J Markussen, I Diers, P Hougaard, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Pharmaceutica Nordica|January 1, 1992
Chemical stability of insulin. 3. Influence of excipients, formulation, and pHJ Brange, L Langkjaer
Pharmaceutical Biotechnology|January 1, 1997
Insulin formulation and deliveryJ Brange, L Langkjaer
Pharmaceutical Research|June 1, 1992
Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparationsJ Brange, L Langkjaer, S Havelund, et al.
BMJ (Clinical Research Ed.)|August 12, 1989
NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogueS Jørgensen, A Vaag, L Langkjaer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 1998
Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatmentL Langkjaer, J Brange, G M Grodsky, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1992
Insulin analogues with improved absorption characteristicsJ Brange, J F Hansen, L Langkjaer, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 1, 1992
Application of the euglycaemic clamp technique to bioassay of insulin analoguesA Vłlund, U Ribel, P L Dam, et al.
Protein Engineering|June 1, 1987
Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30J Markussen, I Diers, A Engesgaard, et al.
Protein Engineering|July 1, 1988
Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30J Markussen, I Diers, P Hougaard, et al.
Pageof 1